HIV/AIDS Clinical Trials

Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women

Condition: HIV

NCT ID: NCT01749566

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics

Condition: HIV Infections

NCT ID: NCT01632995

Pre-Exposure Prophylaxis Using TMC278LA

Condition: HIV Infections

NCT ID: NCT01049932

Terminated

CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM

Condition: Patient Adherence; HIV Seropositivity

NCT ID: NCT01761643

The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)

Condition: HIV Infections

NCT ID: NCT01327651

Recruiting(En español)

First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers

Condition: HIV

NCT ID: NCT01719627

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

Condition: HIV Infection

NCT ID: NCT01473472

Pre-Exposure Prophylaxis in YMSM

Condition: HIV

NCT ID: NCT01033942

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa

Condition: HIV Infection

NCT ID: NCT00931346

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Condition: HIV Infection

NCT ID: NCT01772823

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

Condition: HIV Infections

NCT ID: NCT00971230

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Condition: HIV Infections

NCT ID: NCT00625404

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

Condition: HIV Infection

NCT ID: NCT01769456

Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention

Condition: Clinician Attitudes About PrEP.

NCT ID: NCT01751659

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

Condition: HIV Infection

NCT ID: NCT01275443

Renal, Endocrine, and Bone Changes in Response to TDF/FTC in Uninfected YMSM.

Condition: HIV Infection

NCT ID: NCT01769469

Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation

Condition: HIV Infections

NCT ID: NCT00872261

Active, not recruiting

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men

Condition: HIV Infections

NCT ID: NCT00458393

Recruiting(En español)

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Condition: Pregnancy Outcome

NCT ID: NCT01209754